Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MEndoB, a chimeric lysin featuring a novel domain architecture and superior activity for the treatment of staphylococcal infections

26 Jan 2024

Abstract excerpt

results supporting further development.IMPORTANCEOne of the most pressing challenges of our era is the rising occurrence of bacteria that are resistant to antibiotics. Staphylococci are prominent pathogens in humans, which have developed multiple strategies to evade the effects of antibiotics. Infections caused by these bacteria have resulted in a high burden on the health care system and a significant loss of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimicrobial Peptides and Activities
Share to Antimicrobial Resistance in Staphylococcus
Share to Bacteriophages and microbial interactions

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38275913
DOI: 10.1128/mbio.02540-23

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MEndoB, a chimeric lysin featuring a novel domain architecture and superior activity for the treatment of staphylococcal infectionsPMID 38275913Read ↗

Fusion with a cell wall binding domain renders autolysin LytM a potent anti-Staphylococcus aureus agentSemantic proximity Read ↗

Uncovering novel endolysins against methicillin-resistant <i>Staphylococcus aureus</i> using microbial single-cell genome sequencingSemantic proximity Read ↗

LytM Fusion with SH3b-Like Domain Expands Its Activity to Physiological Conditions.Semantic proximity Read ↗

A chimeric, half-life extended lysin with a unique mode of actionSemantic proximity Read ↗

Evolutionarily distinct bacteriophage endolysins featuring conserved peptidoglycan cleavage sites protect mice from MRSA infectionSemantic proximity Read ↗

Are Phage Lytic Proteins the Secret Weapon To Kill Staphylococcus aureus ?Semantic proximity Read ↗

Functional profiling of CHAP domain-containing peptidoglycan hydrolases of Staphylococcus aureus USA300 uncovers potential targets for anti-staphylococcal therapiesSemantic proximity Read ↗

In Vitro Characterization of PlySK1249, a Novel Phage Lysin, and Assessment of Its Antibacterial Activity in a Mouse Model of Streptococcus agalactiae BacteremiaSemantic proximity Read ↗

β-Lactones as Specific Inhibitors of ClpP Attenuate the Production of Extracellular Virulence Factors of <i>Staphylococcus aureus</i>Semantic proximity Read ↗

Therapeutic applications of lysostaphin against Staphylococcus aureusSemantic proximity Read ↗

Removal of Group B Streptococci Colonizing the Vagina and Oropharynx of Mice with a Bacteriophage Lytic EnzymeSemantic proximity Read ↗

The New SH3b_T Domain Increases the Structural and Functional Variability Among SH3b-Like CBDs from Staphylococcal Phage EndolysinsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.